Prestige Consumer Healthcare Inc. (PBH) Stock Analysis

Prestige Consumer Healthcare (PBH) Q1 2027 Earnings Call Transcript

Thu, August 13, 2026 at 11:29 AM UTC 4 min read

Prestige Consumer Healthcare (PBH) reported its Q1 2027 earnings, showcasing a solid revenue increase driven by strong demand for its over-the-counter products. The company's strategic investments in marketing and product development have positioned it well for future growth. For investors, this positive performance highlights PBH's resilience in a competitive market and reinforces confidence in its long-term profitability.

Read full article →

Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date

Mon, July 6, 2026 at 12:00 PM UTC 2 min read

Prestige Consumer Healthcare Inc. has successfully completed its acquisition of LaCorium Health and announced a $400 million senior notes offering. Additionally, the company revealed the date for its first quarter fiscal 2027 earnings results. This strategic acquisition enhances Prestige's product portfolio, while the notes offering may provide necessary capital for future growth, making it a significant development for investors monitoring the company's expansion and financial health.

Read full article →